RG
DGX icon

Rikoon Group’s Quest Diagnostics DGX Stock Holding History

Rikoon Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$447K Hold
3,480
– – 0.12% 148
2020
Q4 		$415K Hold
3,480
– – 0.12% 148
2020
Q3 		$398K Hold
3,480
– – 0.12% 140
2020
Q2 		$397K Buy
+3,480
New +$369K 0.13% 135

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Rikoon Group's DGX Position: Q1 2021 in Review

Rikoon Group held its Quest Diagnostics (DGX) position steady in Q1 2021 at 3,480 shares worth $447K. The position accounts for 0.12% of the portfolio, ranked #148.

Rikoon Group first reported a position in DGX in Q2 2020 and has held it in 4 quarters since. 818 funds tracked by Wall St. Rank hold DGX as of Q1 2021.

  • Rikoon Group held 3,480 shares of Quest Diagnostics worth $447K as of Q1 2021.
  • Rikoon Group left its Quest Diagnostics share count unchanged in Q1 2021.
  • Quest Diagnostics made up 0.12% of Rikoon Group's portfolio in Q1 2021, its #148 holding.
  • Rikoon Group first reported a position in Quest Diagnostics in Q2 2020 and has held it in 4 quarters since.
  • 818 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2021.

Based on Rikoon Group's 13F filing for Q1 2021, filed 14 May 2021.